Reliq Health Technologies Inc V.RHT.H

Alternate Symbol(s): RQHTF

Healthcare Medical Devices

Reliq Health Technologies Inc. is a global healthcare technology company that specializes in developing virtual care solutions for the healthcare market. The Company’s iUGO Care platform supports care coordination and community-based virtual healthcare. iUGO Care allows complex patients to receive care at home, improving health outcomes, enhancing quality of life for patients and families and reducing the cost of care delivery. iUGO Care provides real-time access to remote patient monitoring data, allowing for timely interventions by the care team to prevent hospital readmissions and ER visits. The iUGO Care platform integrates wearables, sensors, voice technology and mobile apps and desktop user interfaces for patients, clinicians and healthcare administrators. The iUGO Care platform provides services, such as remote patient monitoring, chronic care management, principal care management, behavioral health integration, telemedicine, transitional care management, wound care, and others.

TSXV:RHT.H - Post by User

Reliq Health Technologies Inc > Revenue (lack of) guidance

<< Previous

Bullboard Posts

Next >>

Comment by Reggie1on Feb 05, 2024 6:32pm

95 Views

Post# 35864165

RE:Revenue (lack of) guidance

these people are on delusional drugs or believe your own B S drugs. Just Chris do not expect other to believe your own B S.

We are still on the same trajectory we have always forecasted? That is believing in delusions. That is oblivious.

But its clarity for shareholders right. Its going to take however long its going to take but we will not be able to tell you how long or a timeline. Faith based. They still cannot tell you how money will flow into the organization.

They will need to do another raise and imagine they are talking to potentials now but may have to just flog it to retail. Or my guess is a tute would finance but for a very heavy discount.

lscfa wrote:
Sounds like Crossley's target of $100 million run rate by end of 2024 is no longer.

Chris Shields: I know the ride so far and being an investor with Reliq has been challenging, but I think the fundamentals of the company remain the same. Over the long term people will see that value. It may not be quarter to quarter or even year to year, but if you look back at where we’ve been trending, we’re still on the same trajectory we’ve always forecasted, it’s just taken us longer to get there. We expect to get to our milestone of 100 million in revenue. We’re still on that track. It just may take us longer than we first anticipated to get there.